MicroRNA-148a regulates LDL receptor and ABCA1 expression to control circulating lipoprotein levels
Nature Medicine2015Vol. 21(11), pp. 1280–1289
Citations Over TimeTop 10% of 2015 papers
Leigh Goedeke, Noemí Rotllán, Alberto Canfrán‐Duque, Juan Aranda, Cristina M. Ramírez, Elisa Araldi, Chin‐Sheng Lin, Norma N. Anderson, Alexandre Wagschal, Rafael de Cabo, Jay D. Horton, Miguel A. Lasunción, Anders M. Näär, Yajaira Suárez, Carlos Fernández‐Hernando
Related Papers
- → Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Can Mediate Degradation of the Low Density Lipoprotein Receptor-Related Protein 1 (LRP-1)(2013)231 cited
- → On the function and homeostasis of PCSK9: Reciprocal interaction with LDLR and additional lipid effects(2014)80 cited
- → A New Strategy for Rapidly Screening Natural Inhibitors Targeting the PCSK9/LDLR Interaction In Vitro(2018)15 cited
- Sterol-dependent regulation of proprotein convertase subtilisin/kexin type 9 expression by sterol-regulatory element binding protein-2.(2008)
- → Development and functional analysis of novel PCSK9/LDLR interaction inhibitors for hypercholesterolemia treatment(2021)